Lack of transportation jeopardizes free primary eye care
Short drive times, access to transportation play role in maintaining eye health appointments
20/20 vision can get in the way of a masterpiece
Unraveling role of genetics in the pathogenesis of diabetic retinopathy
Sixty-five genes identified with several belonging to signaling pathways
Hospital utilization and its effects on vision
Here's how hospital stays can affect vision
7 pediatric eye myths parents should stop believing
Regeneron gets FDA approval for Eylea injection prefilled syringe
Online symptom checkers: Do they work?
JAMA Ophthalmology investigates the accuracy claims of this convenient modality
2019 Resident Writers Award Program
Voting for the 2019 Ophthalmology Times Resident Writers Award Program is now open!
Breaking down the dorzolamide shortage
Our supply of dorzolamide, long a first-line glaucoma therapy used alone or in fixed combination with timolol, has recently proven unreliable.
Flying solo poses challenges, flexibility and support vital
Operating a small practice may require physicians to wear many hats
DREAM Extension study supports primary trial conclusion
Supplementation no better than placebo as results confirm previous research
Hospital closures hurt
Impact far-reaching from patients to residency training
New for 2020 and beyond: Dry eye disease agents in pipeline
New compounds could offer more options for physicians in treating patients, leading to better outcomes.
Three-step surgery allays aging, fatigue in lower lid procedure
Dual-plane blepharoplasty can improve tear trough, skin, lower lid position
Controlled trial identifies limited benefits of adjunctive NSAIDs
Research does not support routine use to decrease the risk of PCME
How does diabetic retinopathy influence cataract surgery?
Study compares preoperative risk factors, co-pathology in patients
Teleglaucoma in the community: Taking it to the neighborhood
Established in other areas, telemedicine implementation slow in glaucoma treatment
Reimbursement remains a hurdle for teleglaucoma in United States
Capitated health-care models may be best positioned to take advantage of telehealth
Clinical trial suggests safety of unpreserved levofloxacin
Intracameral injection of cefuroxime, moxifloxacin decrease risk of endophthalmitis
Episode 8: It's time to add IPL therapy to your toolbox
Harvey A. Fishman, MD, PhD, shares why intense pulsed light (IPL) therapy is a valuable asset in any ophthalmologist's toolbox
Intraocular corticosteroid a step forward for postop inflammation
Sustained-release option overcomes limitations of topically administered drops
Can’t beat a good cup of coffee!
Check out the latest Optic Relief!
Tonometry can serve as tool in CME prevention
Research offers guidance on NSAID use, identifies etiologic role of abnormal IOP
Truth or myth?
Exposing the reality of the physician work ethic
Exploring stem cells as neurologic treatment: Not a closed case
While some results have proved to be less than promising, potential remains intact
First treatment for neuromyelitis optica spectrum disorder receives FDA approval
Intravitreal injection treats rare autoimmune disease of the central nervous system
Selective spousal memory
Adenovirus keratitis viral pathogenesis: A persistent enigma
Much has been learned about epidemic keratoconjunctivitis (EKC) since it was first described in 1889.
Antibiotics take aim at postop endophthalmitis
Research shows how drugs work and their selection to reduce infection risk
Fighting fire with fire: Combating burnout among medical educators
Physicians are reporting emotional exhaustion, depersonalization, and decreased accomplishment.
